CommentaryReappraisal of Guidelines for Management of Neonates with Suspected Early-Onset Sepsis
Section snippets
The Evolution of Neonatal Sepsis Risk Assessment
Adoption of intrapartum antibiotic prophylaxis for the prevention of early-onset group B streptococcal (GBS) sepsis since 1995 has resulted in an 85% reduction in the rate of culture-proven early-onset GBS sepsis, from approximately 1.8 per 1000 live births in the early 1990s21 to fewer than 0.25 per 1000 live births22 since 2010. Comparable data for EOS of all causes also reflect a reduction in attack rate, from 2.0 to 2.5 in the late 1980s and 1990s23, 24, 25 to 0.8 to 1.0 per 1000 live
Conclusions
The changing environment and new data require reappraisal of traditional approaches to management of infants at risk for sepsis, with willingness to question and abandon, if necessary, long-held assumptions. Neither identification of maternal risk factors nor screening using laboratory testing is an effective strategy for the ascertainment of infants with EOS in the current era. Recommendation of such approaches in current CDC and AAP recommendations should not prohibit development and adoption
References (54)
- et al.
Enteric gram-negative bacilli bloodstream infections: 17 years' experience in a neonatal intensive care unit
Am J Infect Control
(2004) - et al.
Management of acute chorioamnionitis
Am J Obstet Gynecol
(1980) - et al.
Risk factors for neonatal sepsis
Obstet Gynecol
(1996) - et al.
A multicenter study on the clinical outcome of chorioamnionitis in preterm infants
Am J Obstet Gynecol
(2009) - et al.
Morbidity and mortality among very-low-birth-weight infants born to mothers with clinical chorioamnionitis
Pediatr Neonatol
(2014) Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis
Pediatrics
(1992)Group B streptococcal infections in pregnancy. ACOG Technical Bulletin Number 170
Int J Gynaecol Obstet
(1993)Prevention of perinatal group B streptococcal disease: a public health perspective
MMWR Recomm Rep
(1996)Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion Number 173
Int J Gynaecol Obstet
(1996)Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection
Pediatrics
(1997)
Prevention of perinatal group B streptococcal disease. Revised guidelines from CDC
MMWR Recomm Rep
Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion Number 279
Obstet Gynecol
Prevention of Perinatal Group B Streptococcal Disease—Revised Guidelines from CDC, 2010
MMWR Recomm Rep
Statement of Endorsement—perinatal group B streptococcal disease
Pediatrics
Prevention of early-onset group B streptococcal disease in newborns. ACOG Committee Opinion Number 485
Obstet Gynecol
Recommendations for the prevention of perinatal group B streptococcal (GBS) disease
Pediatrics
Management of neonates with suspected or proven early-onset bacterial sepsis
Pediatrics
The prevention of early-onset group B streptococcal infections in the newborn
Can J Infect Dis
The prevention of early-onset neonatal group B streptococcal disease
J Obstet Gynaecol Can
Prevention of perinatal group B streptococcal infection: management strategies
Can J Infect Dis
Antibiotics for early-onset neonatal infection: Antibiotics for the prevention and treatment of early-onset neonatal infection (CG149)
Prevention of group B streptococcal neonatal disease revisited. The DEVANI European project
Eur J Clin Microbiol Infect Dis
Prevention and management of infants with suspected or proven neonatal sepsis
Pediatrics
2010 perinatal GBS prevention guideline and resource utilization
Pediatrics
Chorioamnionitis: epidemiology of newborn management and outcome United States 2008
J Perinatol
Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis
N Engl J Med
Active Bacterial Core Surveillance (ABCs) Report: Group B streptococcus, 2012
Cited by (123)
Gut microbiome dysbiosis in neonatal sepsis
2022, Progress in Molecular Biology and Translational ScienceCitation Excerpt :There is currently no agreed-upon definition of neonatal sepsis for low- and middle-income countries (LMICs)4 and broadly includes pneumonia, sepsis, meningitis, arthritis, osteomyelitis and urinary tract infections.5 Due to limited blood culture-testing facilities in most secondary hospitals of India and the non-specific features of clinical sepsis, quick and accurate identification of neonates with early onset of sepsis (EOS) is often a huge challenge.6 Moreover, the culture testing results usually take around 48 h and are liable for many false-positive results after antenatal antibiotic exposure.7
Resource Utilization and Costs Associated with Approaches to Identify Infants with Early-Onset Sepsis
2024, MDM Policy and Practice28 NICUs participating in a quality improvement collaborative targeting early-onset sepsis antibiotic use
2024, Journal of Perinatology
J.W. is supported by the National Institutes of Health/National Institute of General Medical Sciences (GM106143). The authors declare no conflicts of interest.